It mimics the effects of the GLP-1 hormone, which helps to increase insulin secretion, decrease glucagon levels, and slow gastric emptying to improve glycemic control
According to the FDA, these medications are approved for people who: Have a BMI* of 30 or higher (classified as obesity), or Have a BMI of 27 or higher (overweight) and at least one weight-related condition, such as high blood pressure, type 2 diabetes, or high cholesterol *While BMI isnt a perfect measurement, its one tool health care providers use to help assess overall health risks
The preventive measures for thrombocytopenia include: Implementing preventive measures can significantly reduce the incidence and severity of thrombocytopenia
10.1016/j.biochi.2021.10.017 47 MartinsF
The GLP-1 and GIP components help counterbalance this effect, but the titration schedule accounts for it by allowing the body to find equilibrium at each dose level before escalating